跳至主要内容
临床试验/CTRI/2023/11/060045
CTRI/2023/11/060045尚未招募Unknown

A randomised controlled trial of vitamin D supplementation on leukocyte telomerase length and telomerase activity in obese Individuals from north Indian with non-alcoholic fatty liver disease. - VITD-NAFLD

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 18-60 years
  • Body Mass Index ( >25 Kg/m2)
  • NAFLD by ultrasound
  • Baseline level of 25 hydroxy vitamin D <30ng/dl.

排除标准

  • a)Known case of diabetes mellitus.
  • b)Known case of HIV infection.
  • c)On any medication within last one month which could potentially influence insulin secretion, insulin sensitivity, vitamin D or calcium metabolism (eg metformin, thiazolidione, steroids etc) and on any medication that activate steroid and xenobiotic receptor and drugs used in transplantation (e.g. steriods, calcitonin etc.)
  • d)Severe end organ damage or chronic diseases: renal/ hepatic failure, any malignancy, nephrotic syndrome, malabsorption etc.
  • e)Primary or tertiary hyperparathyroidism, granulomatous disorders (e.g. sarcoidosis) and any lymphomas

研究者

相似试验

Vitamin D and Liver Health in North India | 临床试验